Selected research
Market Outlook & Growth Opportunities
Global Medical Grade Bioactive Glass Market Outlook and Growth Opportunities 2026
Market perspective
The global Medical Grade Bioactive Glass market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Medical Grade Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Grade Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Grade Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Medical Grade Bioactive Glass market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Medical Grade Bioactive Glass market include Zimmer Biomet Holdings, Inc., Stryker, SCHOTT, BonAlive Biomaterials, NovaBone, Prosidyan, Beijing Xinfuyisheng High Technology, Guangzhou Kejin Material Technology and Ugulin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Medical Grade Bioactive Glass market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Grade Bioactive Glass and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Grade Bioactive Glass sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Grade Bioactive Glass market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Grade Bioactive Glass Segment by Company
Zimmer Biomet Holdings, Inc.
Stryker
SCHOTT
BonAlive Biomaterials
NovaBone
Prosidyan
Beijing Xinfuyisheng High Technology
Guangzhou Kejin Material Technology
Ugulin
Kunshan Overseas Chinese Technology New Materials
Zhangjiagang Lanzhi Biotechnology
Synergy Biomedical
Noraker
Mo-Sci Corporation
Matexcel
Ferro
3M
Medical Grade Bioactive Glass Segment by Type
45S5
S53P4
Others
Medical Grade Bioactive Glass Segment by Application
Bone Materials
Dental Materials
Medical Grade Bioactive Glass Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Medical Grade Bioactive Glass status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Medical Grade Bioactive Glass market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Medical Grade Bioactive Glass significant trends, drivers, influence factors in global and regions.
6. To analyze Medical Grade Bioactive Glass competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Grade Bioactive Glass market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Grade Bioactive Glass and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Grade Bioactive Glass.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medical Grade Bioactive Glass market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Grade Bioactive Glass industry.
Chapter 3: Detailed analysis of Medical Grade Bioactive Glass manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Medical Grade Bioactive Glass in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Medical Grade Bioactive Glass in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 45S5
- S53P4
- Others
Applications
- Bone Materials
- Dental Materials
Companies covered
- Zimmer Biomet Holdings, Inc.
- Stryker
- SCHOTT
- BonAlive Biomaterials
- NovaBone
- Prosidyan
- Beijing Xinfuyisheng High Technology
- Guangzhou Kejin Material Technology
- Ugulin
- Kunshan Overseas Chinese Technology New Materials
- Zhangjiagang Lanzhi Biotechnology
- Synergy Biomedical
- Noraker
- Mo-Sci Corporation
- Matexcel
- Ferro
- 3M
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Medical Grade Bioactive Glass Sales Value (2021-2032)
- 1.2.2 Global Medical Grade Bioactive Glass Sales Volume (2021-2032)
- 1.2.3 Global Medical Grade Bioactive Glass Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Medical Grade Bioactive Glass Market Dynamics
- 2.1 Medical Grade Bioactive Glass Industry Trends
- 2.2 Medical Grade Bioactive Glass Industry Drivers
- 2.3 Medical Grade Bioactive Glass Industry Opportunities and Challenges
- 2.4 Medical Grade Bioactive Glass Industry Restraints
3 Medical Grade Bioactive Glass Market by Company
- 3.1 Global Medical Grade Bioactive Glass Company Revenue Ranking in 2025
- 3.2 Global Medical Grade Bioactive Glass Revenue by Company (2021-2026)
- 3.3 Global Medical Grade Bioactive Glass Sales Volume by Company (2021-2026)
- 3.4 Global Medical Grade Bioactive Glass Average Price by Company (2021-2026)
- 3.5 Global Medical Grade Bioactive Glass Company Ranking (2024-2026)
- 3.6 Global Medical Grade Bioactive Glass Company Manufacturing Base and Headquarters
- 3.7 Global Medical Grade Bioactive Glass Company Product Type and Application
- 3.8 Global Medical Grade Bioactive Glass Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Medical Grade Bioactive Glass Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Medical Grade Bioactive Glass Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Medical Grade Bioactive Glass Market by Type
- 4.1 Medical Grade Bioactive Glass Type Introduction
- 4.1.1 45S5
- 4.1.2 S53P4
- 4.1.3 Others
- 4.2 Global Medical Grade Bioactive Glass Sales Volume by Type
- 4.2.1 Global Medical Grade Bioactive Glass Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Grade Bioactive Glass Sales Volume by Type (2021-2032)
- 4.2.3 Global Medical Grade Bioactive Glass Sales Volume Share by Type (2021-2032)
- 4.3 Global Medical Grade Bioactive Glass Sales Value by Type
- 4.3.1 Global Medical Grade Bioactive Glass Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medical Grade Bioactive Glass Sales Value by Type (2021-2032)
- 4.3.3 Global Medical Grade Bioactive Glass Sales Value Share by Type (2021-2032)
5 Medical Grade Bioactive Glass Market by Application
- 5.1 Medical Grade Bioactive Glass Application Introduction
- 5.1.1 Bone Materials
- 5.1.2 Dental Materials
- 5.2 Global Medical Grade Bioactive Glass Sales Volume by Application
- 5.2.1 Global Medical Grade Bioactive Glass Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Grade Bioactive Glass Sales Volume by Application (2021-2032)
- 5.2.3 Global Medical Grade Bioactive Glass Sales Volume Share by Application (2021-2032)
- 5.3 Global Medical Grade Bioactive Glass Sales Value by Application
- 5.3.1 Global Medical Grade Bioactive Glass Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medical Grade Bioactive Glass Sales Value by Application (2021-2032)
- 5.3.3 Global Medical Grade Bioactive Glass Sales Value Share by Application (2021-2032)
6 Medical Grade Bioactive Glass Regional Sales and Value Analysis
- 6.1 Global Medical Grade Bioactive Glass Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Grade Bioactive Glass Sales by Region (2021-2032)
- 6.2.1 Global Medical Grade Bioactive Glass Sales by Region: 2021-2026
- 6.2.2 Global Medical Grade Bioactive Glass Sales by Region (2027-2032)
- 6.3 Global Medical Grade Bioactive Glass Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Medical Grade Bioactive Glass Sales Value by Region (2021-2032)
- 6.4.1 Global Medical Grade Bioactive Glass Sales Value by Region: 2021-2026
- 6.4.2 Global Medical Grade Bioactive Glass Sales Value by Region (2027-2032)
- 6.5 Global Medical Grade Bioactive Glass Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Medical Grade Bioactive Glass Sales Value (2021-2032)
- 6.6.2 North America Medical Grade Bioactive Glass Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Medical Grade Bioactive Glass Sales Value (2021-2032)
- 6.7.2 Europe Medical Grade Bioactive Glass Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Medical Grade Bioactive Glass Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Medical Grade Bioactive Glass Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Medical Grade Bioactive Glass Sales Value (2021-2032)
- 6.9.2 South America Medical Grade Bioactive Glass Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Medical Grade Bioactive Glass Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Medical Grade Bioactive Glass Sales Value Share by Country, 2025 VS 2032
7 Medical Grade Bioactive Glass Country-level Sales and Value Analysis
- 7.1 Global Medical Grade Bioactive Glass Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Medical Grade Bioactive Glass Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Medical Grade Bioactive Glass Sales by Country (2021-2032)
- 7.3.1 Global Medical Grade Bioactive Glass Sales by Country (2021-2026)
- 7.3.2 Global Medical Grade Bioactive Glass Sales by Country (2027-2032)
- 7.4 Global Medical Grade Bioactive Glass Sales Value by Country (2021-2032)
- 7.4.1 Global Medical Grade Bioactive Glass Sales Value by Country (2021-2026)
- 7.4.2 Global Medical Grade Bioactive Glass Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.9.2 France Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.16.2 China Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.19.2 India Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Medical Grade Bioactive Glass Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Medical Grade Bioactive Glass Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Medical Grade Bioactive Glass Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Zimmer Biomet Holdings, Inc.
- 8.1.1 Zimmer Biomet Holdings, Inc. Company Information
- 8.1.2 Zimmer Biomet Holdings, Inc. Business Overview
- 8.1.3 Zimmer Biomet Holdings, Inc. Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Zimmer Biomet Holdings, Inc. Medical Grade Bioactive Glass Product Portfolio
- 8.1.5 Zimmer Biomet Holdings, Inc. Recent Developments
- 8.2 Stryker
- 8.2.1 Stryker Company Information
- 8.2.2 Stryker Business Overview
- 8.2.3 Stryker Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Stryker Medical Grade Bioactive Glass Product Portfolio
- 8.2.5 Stryker Recent Developments
- 8.3 SCHOTT
- 8.3.1 SCHOTT Company Information
- 8.3.2 SCHOTT Business Overview
- 8.3.3 SCHOTT Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.3.4 SCHOTT Medical Grade Bioactive Glass Product Portfolio
- 8.3.5 SCHOTT Recent Developments
- 8.4 BonAlive Biomaterials
- 8.4.1 BonAlive Biomaterials Company Information
- 8.4.2 BonAlive Biomaterials Business Overview
- 8.4.3 BonAlive Biomaterials Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.4.4 BonAlive Biomaterials Medical Grade Bioactive Glass Product Portfolio
- 8.4.5 BonAlive Biomaterials Recent Developments
- 8.5 NovaBone
- 8.5.1 NovaBone Company Information
- 8.5.2 NovaBone Business Overview
- 8.5.3 NovaBone Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.5.4 NovaBone Medical Grade Bioactive Glass Product Portfolio
- 8.5.5 NovaBone Recent Developments
- 8.6 Prosidyan
- 8.6.1 Prosidyan Company Information
- 8.6.2 Prosidyan Business Overview
- 8.6.3 Prosidyan Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Prosidyan Medical Grade Bioactive Glass Product Portfolio
- 8.6.5 Prosidyan Recent Developments
- 8.7 Beijing Xinfuyisheng High Technology
- 8.7.1 Beijing Xinfuyisheng High Technology Company Information
- 8.7.2 Beijing Xinfuyisheng High Technology Business Overview
- 8.7.3 Beijing Xinfuyisheng High Technology Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Beijing Xinfuyisheng High Technology Medical Grade Bioactive Glass Product Portfolio
- 8.7.5 Beijing Xinfuyisheng High Technology Recent Developments
- 8.8 Guangzhou Kejin Material Technology
- 8.8.1 Guangzhou Kejin Material Technology Company Information
- 8.8.2 Guangzhou Kejin Material Technology Business Overview
- 8.8.3 Guangzhou Kejin Material Technology Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Guangzhou Kejin Material Technology Medical Grade Bioactive Glass Product Portfolio
- 8.8.5 Guangzhou Kejin Material Technology Recent Developments
- 8.9 Ugulin
- 8.9.1 Ugulin Company Information
- 8.9.2 Ugulin Business Overview
- 8.9.3 Ugulin Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Ugulin Medical Grade Bioactive Glass Product Portfolio
- 8.9.5 Ugulin Recent Developments
- 8.10 Kunshan Overseas Chinese Technology New Materials
- 8.10.1 Kunshan Overseas Chinese Technology New Materials Company Information
- 8.10.2 Kunshan Overseas Chinese Technology New Materials Business Overview
- 8.10.3 Kunshan Overseas Chinese Technology New Materials Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Kunshan Overseas Chinese Technology New Materials Medical Grade Bioactive Glass Product Portfolio
- 8.10.5 Kunshan Overseas Chinese Technology New Materials Recent Developments
- 8.11 Zhangjiagang Lanzhi Biotechnology
- 8.11.1 Zhangjiagang Lanzhi Biotechnology Company Information
- 8.11.2 Zhangjiagang Lanzhi Biotechnology Business Overview
- 8.11.3 Zhangjiagang Lanzhi Biotechnology Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Zhangjiagang Lanzhi Biotechnology Medical Grade Bioactive Glass Product Portfolio
- 8.11.5 Zhangjiagang Lanzhi Biotechnology Recent Developments
- 8.12 Synergy Biomedical
- 8.12.1 Synergy Biomedical Company Information
- 8.12.2 Synergy Biomedical Business Overview
- 8.12.3 Synergy Biomedical Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Synergy Biomedical Medical Grade Bioactive Glass Product Portfolio
- 8.12.5 Synergy Biomedical Recent Developments
- 8.13 Noraker
- 8.13.1 Noraker Company Information
- 8.13.2 Noraker Business Overview
- 8.13.3 Noraker Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Noraker Medical Grade Bioactive Glass Product Portfolio
- 8.13.5 Noraker Recent Developments
- 8.14 Mo-Sci Corporation
- 8.14.1 Mo-Sci Corporation Company Information
- 8.14.2 Mo-Sci Corporation Business Overview
- 8.14.3 Mo-Sci Corporation Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Mo-Sci Corporation Medical Grade Bioactive Glass Product Portfolio
- 8.14.5 Mo-Sci Corporation Recent Developments
- 8.15 Matexcel
- 8.15.1 Matexcel Company Information
- 8.15.2 Matexcel Business Overview
- 8.15.3 Matexcel Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Matexcel Medical Grade Bioactive Glass Product Portfolio
- 8.15.5 Matexcel Recent Developments
- 8.16 Ferro
- 8.16.1 Ferro Company Information
- 8.16.2 Ferro Business Overview
- 8.16.3 Ferro Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Ferro Medical Grade Bioactive Glass Product Portfolio
- 8.16.5 Ferro Recent Developments
- 8.17 3M
- 8.17.1 3M Company Information
- 8.17.2 3M Business Overview
- 8.17.3 3M Medical Grade Bioactive Glass Sales, Value and Gross Margin (2021-2026)
- 8.17.4 3M Medical Grade Bioactive Glass Product Portfolio
- 8.17.5 3M Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Medical Grade Bioactive Glass Value Chain Analysis
- 9.1.1 Medical Grade Bioactive Glass Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medical Grade Bioactive Glass Sales Mode & Process
- 9.2 Medical Grade Bioactive Glass Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medical Grade Bioactive Glass Distributors
- 9.2.3 Medical Grade Bioactive Glass Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst